Premium
Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon‐alpha treatment for hepatitis C virus infection
Author(s) -
Akay BN,
Ekmekci P,
Sanli H,
Celik G,
Bozdayi M
Publication year - 2006
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2006.01450.x
Subject(s) - medicine , sarcoidosis , alpha interferon , immunology , hepatitis c virus , interferon , cutaneous sarcoidosis , virus , hepatitis c
A patient with hepatitis C virus (HCV) infection was diagnosed with cutaneous, pulmonary and hepatic sarcoidosis following interferon alpha therapy. There are only a few cases of sarcoidosis associated with this treatment. This is the first case who not only developed sarcoidosis, but also autoimmune hypothyroidism and thrombocytopenia during interferon alpha therapy due to the immunomodulatory effects of the drug.